, United Nations Office on Drugs and Crime. World Drug Report, 2019.

. Dress-i, Enquête nationale pé rinatale 2016. Les naissances et les é tablissements, situation et é volution depuis 2010 -Ministè re des Solidarité s et de la Santé, 2016.

M. Maccarrone, E. Dainese, and S. Oddi, Intracellular trafficking of anandamide: new concepts for signaling, Trends Biochem Sci, vol.35, pp.601-609, 2010.

B. C. Paria, W. Ma, D. M. Andrenyak, P. C. Schmid, H. H. Schmid et al., Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors, Biol Reprod, vol.58, pp.1490-1495, 1998.

G. Tortoriello, C. V. Morris, A. Alpar, J. Fuzik, S. L. Shirran et al., Miswiring the brain: D9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway, EMBO J, vol.33, pp.668-85, 2014.

D. E. Newton, Marijuana: a reference handbook, ABC-CLIO, 2013.

M. Paczesny, Cannabis sativa L. : é tude botanique et chimique : proprié té s mé dicales et é tat des lieux sur la ré glementation, 2014.
URL : https://hal.archives-ouvertes.fr/dumas-00983072

Y. Gaoni and R. Mechoulam, Isolation, structure, and partial synthesis of an active constituent of Hashish, J Am Chem Soc, vol.86, pp.1646-1653, 1964.

S. Pisanti, A. M. Malfitano, E. Ciaglia, A. Lamberti, R. Ranieri et al., Cannabidiol: state of the art and new challenges for therapeutic applications, Pharmacol Ther, vol.175, pp.133-50, 2017.

T. Né-fau, Le point SINTES -numé ro 4. WwwOfdtFr, 2019.

R. C. Clarke and D. P. Watson, Cannabis and natural cannabis medicines, pp.1-15, 2007.

C. Blackard and K. Tennes, Human placental transfer of cannabinoids, N Engl J Med, vol.311, p.797, 1984.

J. R. Bailey, H. C. Cunny, M. G. Paule, and W. Slikker, Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey

, Toxicol Appl Pharmacol, vol.90, pp.90338-90341, 1987.

M. R. Elphick, The evolution and comparative neurobiology of endocannabinoid signalling, Philos Trans R Soc Lond B Biol Sci, vol.367, pp.3201-3216, 2012.

B. Lutz, G. Marsicano, R. Maldonado, and C. J. Hillard, The endocannabinoid system in guarding against fear, anxiety and stress, Nat Rev Neurosci, vol.16, pp.705-723, 2015.

A. Ligresti, L. De-petrocellis, D. Marzo, and V. , From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology, Physiol Rev, vol.96, pp.1593-659, 2016.

R. Mechoulam, E. Fride, D. Marzo, and V. Endocannabinoids, Eur J Pharmacol, vol.359, pp.1-18, 1998.

N. Ueda, K. Tsuboi, and T. Uyama, Metabolism of endocannabinoids and related Nacylethanolamines: canonical and alternative pathways, FEBS J, vol.280, pp.1874-94, 2013.

A. Chicca, J. Marazzi, S. Nicolussi, and J. Gertsch, Evidence for bidirectional endocannabinoid transport across cell membranes, J Biol Chem, vol.287, pp.34660-82, 2012.

N. Ueda, K. Tsuboi, T. Uyama, and T. Ohnishi, Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol, BioFactors, vol.37, pp.1-7, 2011.

A. C. Howlett, Handbook of experimental pharmacology, vol.168

, , pp.53-79, 2005.

G. Pearson, F. Robinson, T. B. Gibson, B. Xu, M. Karandikar et al., Mitogen-Activated Protein (MAP) Kinase Pathways, Regulat Physiol Funct, vol.22, p.31, 2001.

M. Almada, B. M. Fonseca, C. Amaral, M. Diniz-da-costa, G. Correia-da-silva et al., Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis, Apoptosis, vol.22, pp.816-842, 2017.

R. G. Pertwee, A. C. Howlett, M. E. Abood, S. Alexander, D. Marzo et al., International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2, Pharmacol Rev, vol.62, pp.588-631, 2010.

R. Diez-alarcia, I. Ibarra-lecue, A. P. Lopez-cardona, J. Meana, A. Gutierrez-adá-n et al., Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex, Front Pharmacol, vol.7, 2016.

B. F. Cravatt, D. K. Giang, S. P. Mayfield, D. L. Boger, R. A. Lerner et al., Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature, vol.384, pp.83-90, 1996.

Q. L. Brown, A. L. Sarvet, D. Shmulewitz, S. S. Martins, M. M. Wall et al., Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, JAMA, vol.317, pp.207-216, 2002.

S. Oh, C. P. Salas-wright, M. G. Vaughn, and D. M. Dinitto, Marijuana use during pregnancy: a comparison of trends and correlates among married and unmarried pregnant women, Drug Alcohol Dependence, vol.181, pp.229-262, 2017.

H. El-marroun, H. Tiemeier, V. Jaddoe, A. Hofman, J. P. Mackenbach et al., Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study, Drug Alcohol Dependence, vol.98, pp.218-244, 2008.

J. Y. Ko, S. L. Farr, V. T. Tong, A. A. Creanga, and W. M. Callaghan, Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age

, Am J Obstet Gynecol, vol.213, pp.201-202, 2015.

A. Chiandetti, G. Hernandez, M. Mercadal-hally, A. Alvarez, V. Andreu-fernandez et al., Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers, Reprod Health, vol.14, p.137, 2017.

K. C. Young-wolff, L. Tucker, S. Alexeeff, M. A. Armstrong, A. Conway et al., Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009-2016, JAMA, vol.318, p.2490, 2017.

K. Mark, J. Gryczynski, E. Axenfeld, R. P. Schwartz, and M. Terplan, Pregnant women's current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm, J Addict Med, vol.11, pp.211-217, 2017.

J. R. Beatty, D. S. Svikis, and S. J. Ondersma, Prevalence and perceived financial costs of marijuana versus tobacco use among urban low-income pregnant women, J Addict Res Ther, vol.3, 2012.

M. Jarlenski, J. W. Koma, J. Zank, L. M. Bodnar, D. L. Bogen et al., Trends in perception of risk of regular marijuana use among US pregnant and nonpregnant reproductive-aged women, Am J Obstet Gynecol, vol.217, pp.705-712, 2017.

M. R. El-talatini, A. H. Taylor, J. C. Elson, L. Brown, A. C. Davidson et al., Localisation and function of the endocannabinoid system in the human ovary, PLoS ONE, vol.4, p.4579, 2009.

P. C. Schmid, B. C. Paria, R. J. Krebsbach, H. H. Schmid, and S. K. Dey, Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation, Proc Natl Acad Sci, vol.94, pp.4188-92, 1997.

B. Park, J. M. Mcpartland, and M. Glass, Cannabis, cannabinoids and reproduction, Prostaglandins Leukotrienes and Essential Fatty Acids, vol.70, pp.189-97, 2004.

T. Wenger, . Tó, . Be, and B. R. Martin, Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats, Life Sci, vol.56, pp.2057-63, 1995.

D. Blasio, A. M. Vignali, M. Gentilini, and D. , The endocannabinoid pathway and the female reproductive organs, J Mol Endocrinol, vol.50, pp.1-9, 2013.

R. G. Almirez, C. G. Smith, and R. H. Asch, The effects of marijuana extract and delta 9-tetrahydrocannabinol on luteal function in the rhesus monkey, Fertil Steril, vol.39, pp.212-219, 1983.

I. Chakravarty, P. G. Shah, A. R. Sheth, and J. J. Ghosh, Mode of action of delta-9-tetrahydrocannabinol on hypothalamo-pituitary function in adult female rats, Reproduction, vol.57, pp.113-118, 1979.

R. H. Asch, C. G. Smith, T. M. Siler-khodr, and C. J. Pauerstein, Effects of delta 9-tetrahydrocannabinol during the follicular phase of the rhesus monkey (Macaca mulatta), J Clin Endocrinol Metab, vol.52, pp.50-55, 1981.

B. A. Mueller, J. R. Daling, N. S. Weiss, and D. E. Moore, Recreational drug use and the risk of primary infertility, Epidemiology, vol.1, pp.195-200, 1990.

H. S. Klonoff-cohen, L. Natarajan, V. Chen, and R. , A prospective study of the effects of female and male marijuana use on in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) outcomes, Am J Obstet Gynecol, vol.194, pp.369-76, 2006.

J. H. Mendelson, N. K. Mello, J. Ellingboe, A. S. Skupny, B. W. Lex et al., Marihuana smoking suppresses luteinizing hormone in women, J Pharmacol Exp Ther, vol.237, pp.862-868, 1986.

R. Sharma, K. R. Biedenharn, J. M. Fedor, and A. Agarwal, Lifestyle factors and reproductive health: taking control of your fertility, Reprod Biol Endocrinol, vol.11, p.66, 2013.

O. S. Walker, A. C. Holloway, and S. Raha, The role of the endocannabinoid system in female reproductive tissues, J Ovarian Res, vol.12, 2019.

H. Wang, Y. Guo, D. Wang, P. J. Kingsley, L. J. Marnett et al., Aberrant cannabinoid signaling impairs oviductal transport of embryos, Nat Med, vol.10, pp.1074-80, 2004.

H. Wang, H. Xie, Y. Guo, H. Zhang, T. Takahashi et al., Fatty acid amide hydrolase deficiency limits early pregnancy events, J Clin Invest, vol.116, pp.2122-2153, 2006.

A. K. Gebeh, J. M. Willets, E. L. Marczylo, A. H. Taylor, and J. C. Konje, Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes, J Clin Endocrinol Metabol, vol.97, pp.2827-2862, 2012.

H. Matsumoto, Molecular and cellular events during blastocyst implantation in the receptive uterus: clues from mouse models, J Reprod Dev, vol.63, pp.445-54, 2017.

L. K. Brents, Marijuana, the endocannabinoid system and the female reproductive system, Yale J Biol Med, vol.89, pp.175-91, 2016.

M. Maccarrone, H. Valensise, M. Bari, N. Lazzarin, C. Romanini et al., Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage, Lancet, vol.355, pp.1326-1335, 2000.

M. R. El-talatini, A. H. Taylor, and J. C. Konje, The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle, Fertil Steril, vol.93, pp.1989-96, 2010.

M. A. Costa, B. M. Fonseca, N. A. Teixeira, and G. Correia-da-silva, The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways, Placenta, vol.36, pp.69-76, 2015.

M. A. Costa, E. Keating, B. M. Fonseca, N. A. Teixeira, and G. Correia-da-silva, 2-Arachidonoylglycerol impairs human cytotrophoblast cells syncytialization: influence of endocannabinoid signalling in placental development, Mol Cellular Endocrinol, vol.399, pp.386-94, 2015.

M. A. Costa, B. M. Fonseca, F. Marques, N. A. Teixeira, and G. Correia-da-silva, The psychoactive compound of Cannabis sativa, D9-tetrahydrocannabinol (THC) inhibits the human trophoblast cell turnover, Toxicology, vol.334, pp.94-103, 2015.

M. Almada, L. Costa, B. M. Fonseca, C. Amaral, N. Teixeira et al., The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor, Toxicology, vol.385, pp.67-73, 2017.

J. Gunn, C. B. Rosales, K. E. Center, A. Nuñ-ez, S. J. Gibson et al., Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis, BMJ Open, vol.6, p.9986, 2016.

S. N. Conner, V. Bedell, K. Lipsey, G. A. Macones, A. G. Cahill et al., Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis, Obstet Gynecol, vol.128, pp.713-736, 2016.

V. H. Coleman-cowger, E. A. Oga, E. N. Peters, and K. Mark, Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy, Neurotoxicol Teratol, vol.68, pp.84-90, 2018.

L. W. Chamley, A. Bhalla, P. R. Stone, H. Liddell, O. Carroll et al., Nuclear localisation of the endocannabinoid metabolizing enzyme fatty acid amide hydrolase (FAAH) in invasive trophoblasts and an association with recurrent miscarriage, Placenta, vol.29, pp.970-975, 2008.

A. Hofman, V. Jaddoe, J. P. Mackenbach, H. A. Moll, R. Snijders et al., Growth, development and health from early fetal life until young adulthood: the Generation R Study, Paediatr Perinat Epidemiol, vol.18, pp.61-72, 2004.

M. R. Hayatbakhsh, V. J. Flenady, K. S. Gibbons, A. M. Kingsbury, E. Hurrion et al., Birth outcomes associated with cannabis use before and during pregnancy, Pediatr Res, vol.71, pp.215-224, 2012.

S. Y. Leemaqz, G. A. Dekker, L. M. Mccowan, L. C. Kenny, J. E. Myers et al., Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications, Reprod Toxicol, vol.62, pp.77-86, 2016.

M. Saurel-cubizolles, C. Prunet, and B. Blondel, Cannabis use during pregnancy in France in 2010, BJOG, vol.121, pp.971-978, 2014.

G. A. Dekker, S. Y. Lee, R. A. North, L. M. Mccowan, N. Simpson et al., Risk factors for preterm birth in an international prospective cohort of nulliparous women, PLoS ONE, vol.7, 2012.

E. E. Hatch and M. B. Bracken, Effect of marijuana use in pregnancy on fetal growth, Am J Epidemiol, vol.124, pp.986-93, 1986.

R. M. Kliegman, D. Madura, R. Kiwi, I. Eisenberg, and T. Yamashita, Relation of maternal cocaine use to the risks of prematurity and low birth weight, J Pediatrics, vol.124, pp.751-757, 1994.

P. H. Shiono, M. A. Klebanoff, R. P. Nugent, M. F. Cotch, D. G. Wilkins et al., The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study, Am J Obstet Gynecol, vol.172, pp.19-27, 1995.

M. Van-gelder, J. Reefhuis, A. R. Caton, M. M. Werler, C. M. Druschel et al., Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study, Drug Alcohol Dependence, vol.109, pp.243-250, 2010.

C. R. Warshak, J. Regan, B. Moore, K. Magner, S. Kritzer et al., Association between marijuana use and adverse obstetrical and neonatal outcomes, J Perinatol, vol.35, pp.991-996, 2015.

T. D. Metz, A. A. Allshouse, C. J. Hogue, R. L. Goldenberg, D. J. Dudley et al., Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity, Am J Obstet Gynecol, vol.217, pp.478-479, 2017.

X. Sun and S. K. Dey, Endocannabinoid signaling in female reproduction, ACS Chem Neurosci, vol.3, pp.349-55, 2012.

K. A. Richardson, A. K. Hester, and G. L. Mclemore, Prenatal cannabis exposure -The ''first hit'' to the endocannabinoid system, Neurotoxicol Teratol, vol.58, pp.5-14, 2016.

T. P. Fleming, M. A. Velazquez, J. J. Eckert, D. Embryos, and D. Barker, J Dev Origins Health Dis, vol.6, pp.377-83, 2015.